checkAd

     206  0 Kommentare Co-Diagnostics Announces $5.0 Million Registered Direct Offering Priced At-the-Market - Seite 3

    Lesen Sie auch


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Weitere Artikel des Autors

    Seite 3 von 3

    Co-Diagnostics Announces $5.0 Million Registered Direct Offering Priced At-the-Market - Seite 3 Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered into definitive agreements with institutional investors for …